AMERICAN INTERNATIONAL GROUP, INC. - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$431,498
-60.5%
46,051
+3.4%
0.00%
-57.1%
Q2 2023$1,092,934
+18.0%
44,555
+11.9%
0.01%
+16.7%
Q1 2023$926,146
-7.7%
39,800
+0.4%
0.01%
-14.3%
Q4 2022$1,003,516
+30.3%
39,649
-0.7%
0.01%
+16.7%
Q3 2022$770,000
-23.3%
39,947
+1.4%
0.01%
-14.3%
Q2 2022$1,004,000
+30.7%
39,408
+32.0%
0.01%
+75.0%
Q1 2022$768,000
-42.6%
29,846
-6.6%
0.00%
-42.9%
Q4 2021$1,338,000
-6.6%
31,946
-2.9%
0.01%
-12.5%
Q3 2021$1,432,000
-10.1%
32,903
-2.3%
0.01%
+60.0%
Q2 2021$1,593,000
-0.5%
33,684
+7.9%
0.01%
-16.7%
Q1 2021$1,601,000
+92.0%
31,227
+0.3%
0.01%
+100.0%
Q4 2020$834,000
-24.2%
31,145
-2.8%
0.00%
-40.0%
Q3 2020$1,100,000
-5.2%
32,039
+13.1%
0.01%
-16.7%
Q2 2020$1,160,000
+694.5%
28,318
+564.0%
0.01%
+500.0%
Q1 2020$146,000
+156.1%
4,265
-5.5%
0.00%
Q4 2019$57,0004,5120.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$30,100,00023.79%
SB INVESTMENT ADVISERS (UK) LTD 22,086,280$425,823,0003.26%
Zebra Capital Management LLC 40,104$773,0002.94%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 130,409$2,514,0000.94%
CLARK ESTATES INC/NY 180,000$3,470,0000.77%
Temasek Holdings (Private) Ltd 6,036,821$116,389,9090.70%
SECTOR GAMMA AS 89,808$1,731,0000.45%
Capital Impact Advisors, LLC 13,196$360,0000.36%
SummerHaven Investment Management, LLC 24,927$481,0000.33%
DUALITY ADVISERS, LP 92,712$1,787,0000.20%
View complete list of VIR BIOTECHNOLOGY INC shareholders